CX Industries is the wholly-owned subsidiary of WeedMD that specializes in extraction, toll processing, and third-party product formulation.
Read More![CURE Pharmaceutical [OTC: CURR] Names Canopy Rivers’ Chairman, John K. Bell, To Board of Directors](https://www.investinweed.com/wp-content/uploads/Cure-Pharmaceutical-627x376.png)
John’s unparalleled depth and breadth of expertise makes him an invaluable asset to CURE Pharmaceutical’s growth strategy.
Read More
The company is pleased to announce Robert (Bobby) Kwon will join MediPharm Labs as Chief Financial Officer (CFO), effective November 18, 2019.
Read More
Burk has more than 25 years of experience as a legal and compliance strategist including 15 years with Aon.
Read More
The company announced the appointment of Beth Altman to its Board of Directors effective October 24, 2019.
Read More
Get stock alerts, news & related alerts straight to your inbox!